サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439228

血糖モニタリングシステム - 世界市場の考察、競合情勢、市場予測（2030年）

Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
血糖モニタリングシステム - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血糖モニタリングシステムの市場規模は、2023年に130億6,000万米ドル、2030年までに204億米ドルに達し、2024年～2030年の予測期間にCAGRで7.72％の成長が見込まれます。血糖モニタリングシステムに対する需要の高まりは、世界中の人々の糖尿病有病率の増加や、高血糖を発症しやすい老年人口の負担の増大が主な原因です。加えて、先進技術を利用した血糖モニタリングデバイス製品の発売や、適切な糖尿病管理に関する意識を高める政府の取り組みなどの急増は、世界の血糖モニタリングシステム市場を促進する可能性が高い要因です。

血糖モニタリングシステムの市場力学

血糖モニタリングシステム市場は、世界の人々の糖尿病有病率の増加により、現在勢いを増しています。International Diabetes Federation Atlas Ninth（2019）によると、2019年に世界中で20～79歳の成人約4億6,300万人が糖尿病とともに生活しており、2045年までに7億人に増加すると予測されています。

上記の資料はまた、約110万人の子供と青少年が1型糖尿病とともに生活しており、約2,000万人の生児（生児の6人に1人）が妊娠中に糖尿病の影響を受けていると述べています。したがって、糖尿病の適切な管理には適切な血糖モニタリングが必要であり、このことが予測期間に血糖モニタリングシステムの需要を増加させます。

また、糖尿病を発症しやすい老年人口の増加は、血糖モニタリングシステムの需要を高めると予測されます。United Nations World Population Ageing 2019のハイライトによると、2019年の世界の65歳以上の高齢者数は約7億300万人であり、2050年までに高齢者数は15億人に倍増すると予測されています。さらに、American Diabetes Associationの2022年のデータによると、65歳以上の米国人の糖尿病患者の割合は2018年に26.8％であり、米国では1,430万人の高齢者が糖尿病に罹患しており、依然として高い水準にあります。

さらに、先進技術を利用した血糖モニタリングシステムの承認も、血糖モニタリングシステムの市場を急成長させると予測されています。例えば2020年9月28日、Abbottは世界最小かつ最薄のセンサーで構成され、持続的かつリアルタイムの血糖値をスマートフォンに自動配信する次世代システム「FreeStyle Libre 3」のCEマークを取得しました。

したがって、前述のすべての要因が、予測期間に血糖モニタリングシステム市場に寄与すると予測されます。

しかし、血糖モニタリングシステムに関連する高いコストは、市場を抑制する可能性が高いです。

前例のないCOVID-19パンデミックが血糖モニタリングシステムに及ぼす影響は限定的です。なぜなら、COVID-19パンデミック中に病院での家庭用血糖測定器の使用に対するFDAガイドラインが発行され、これにより遠隔患者モニタリングが促進されうるからです。さらに、COVID-19の緊急時に入院患者への持続血糖モニタリングシステムの使用を拡大し、病院スタッフが患者の血糖を遠隔モニタリングできるようにしたことも、全国的なロックダウンや需要の低迷、ロジスティクス上の制約によるサプライチェーンにもかかわらず、血糖モニタリングシステムの需要を押し上げました。

血糖モニタリングシステム市場のセグメント分析

血糖モニタリングシステム製品セグメントでは、予測期間に持続血糖モニタリングシステム（CGM）が大きな市場シェアを占めると予測されています。これは、CGMシステムは血糖コントロールの改善に向けて単一の測定値を示すのではなく、グルコースレベルの動向に関するリアルタイムかつ動的な情報を提供するという利点が、これらのシステムの需要を高める可能性が高いためです。

当レポートでは、世界の血糖モニタリングシステム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血糖モニタリングシステム市場レポートのイントロダクション

第2章 血糖モニタリングシステム市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 血糖モニタリングシステム市場の主な要因の分析

  • 血糖モニタリングシステム市場の促進要因
    • 糖尿病の有病率の増加
    • 高齢者の負担の増大
    • さまざまな血糖モニタリングシステムの承認の増加
    • 製品の急速な技術の進歩
  • 血糖モニタリングシステム市場の抑制要因と課題
    • 血糖モニタリングシステムの高いコスト
    • 新興国における診断率と治療率の低下により、血糖モニタリングシステムの採用が制限される可能性がある
  • 血糖モニタリングシステム市場の機会
    • 主要企業による市場拡大に向けた戦略的な事業活動も成長機会をもたらす
    • 低中所得国における意識を向上させる政府の取り組みの高まりが市場に機会をもたらす可能性がある

第5章 血糖モニタリングシステムのポーターのファイブフォース分析

第6章 血糖モニタリングシステム市場に対するCOVID-19の影響の分析

第7章 血糖モニタリングシステム市場のレイアウト

  • 製品タイプ別
    • 血糖セルフモニタリングシステム
    • 持続血糖モニタリングシステム
  • モダリティ別
    • ウェアラブル
    • 非ウェアラブル
  • エンドユーザー別
    • 病院
    • 在宅ケア環境
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 血糖モニタリングシステム：世界の企業シェア分析 - 主要3～5社

第9章 血糖モニタリングシステムの企業と製品のプロファイル

  • Medtronic
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • LifeScan IP Holdings (Johnson & Johnson)
  • Dexcom Inc.
  • ARKRAY, Inc.
  • Senseonics
  • WaveForm Technologies, Inc.
  • B. Braun Melsungen AG
  • Ascensia Diabetes Care Holdings AG.
  • Ypsomed
  • i-SENS, Inc.
  • Intuity Medical, Inc.
  • ACON Laboratories, Inc.
  • Prodigy Diabetes Care, LLC
  • Sinocare
  • Rossmax International Ltd.
  • Menarini Diagnostics s.r.l
  • Bionime Corporation.
  • Nemaura.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market
  • Table 3 Blood Glucose Monitoring Systems Market Analysis in Global (2021-2030)
  • Table 4 Blood Glucose Monitoring Systems Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Blood Glucose Monitoring Systems Market Analysis in Global by Modality (2021-2030)
  • Table 6 Blood Glucose Monitoring Systems Market Analysis in Global by End User (2021-2030)
  • Table 7 Blood Glucose Monitoring Systems Market Analysis in Global by Geography (2021-2030)
  • Table 8 Blood Glucose Monitoring Systems Market Analysis in North America (2021-2030)
  • Table 9 Blood Glucose Monitoring Systems Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Blood Glucose Monitoring Systems Market Analysis in North America by Modality (2021-2030)
  • Table 11 Blood Glucose Monitoring Systems Market Analysis in North America by End User (2021-2030)
  • Table 12 Blood Glucose Monitoring Systems Market Analysis in North America by Country (2021-2030)
  • Table 13 Blood Glucose Monitoring Systems Market Analysis in the US (2021-2030)
  • Table 14 Blood Glucose Monitoring Systems Market Analysis in Canada (2021-2030)
  • Table 15 Blood Glucose Monitoring Systems Market Analysis in Mexico (2021-2030)
  • Table 16 Blood Glucose Monitoring Systems Market Analysis in Europe (2021-2030)
  • Table 17 Blood Glucose Monitoring Systems Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Blood Glucose Monitoring Systems Market Analysis in Europe by Modality (2021-2030)
  • Table 19 Blood Glucose Monitoring Systems Market Analysis in Europe by End User (2021-2030)
  • Table 20 Blood Glucose Monitoring Systems Market Analysis in Europe by Country (2021-2030)
  • Table 21 Blood Glucose Monitoring Systems Market Analysis in France (2021-2030)
  • Table 22 Blood Glucose Monitoring Systems Market Analysis in Germany (2021-2030)
  • Table 23 Blood Glucose Monitoring Systems Market Analysis in the UK (2021-2030)
  • Table 24 Blood Glucose Monitoring Systems Market Analysis in Italy (2021-2030)
  • Table 25 Blood Glucose Monitoring Systems Market Analysis in Spain (2021-2030)
  • Table 26 Blood Glucose Monitoring Systems Market Analysis in Russia (2021-2030)
  • Table 27 Blood Glucose Monitoring Systems Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Modality (2021-2030)
  • Table 31 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Blood Glucose Monitoring Systems Market Analysis in China (2021-2030)
  • Table 34 Blood Glucose Monitoring Systems Market Analysis in Japan (2021-2030)
  • Table 35 Blood Glucose Monitoring Systems Market Analysis in India (2021-2030)
  • Table 36 Blood Glucose Monitoring Systems Market Analysis in Australia (2021-2030)
  • Table 37 Blood Glucose Monitoring Systems Market Analysis in South Korea (2021-2030)
  • Table 38 Blood Glucose Monitoring Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Blood Glucose Monitoring Systems Market Analysis in Rest of World (2021-2030)
  • Table 40 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Modality (2021-2030)
  • Table 42 Blood Glucose Monitoring Systems Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Blood Glucose Monitoring Systems Market Analysis in the Middle East (2021-2030)
  • Table 45 Blood Glucose Monitoring Systems Market Analysis in Africa (2021-2030)
  • Table 46 Blood Glucose Monitoring Systems Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market
  • Figure 3 Blood Glucose Monitoring Systems Market Analysis in Global (2021-2030)
  • Figure 4 Blood Glucose Monitoring Systems Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Blood Glucose Monitoring Systems Market Analysis in Global by Modality (2021-2030)
  • Figure 6 Blood Glucose Monitoring Systems Market Analysis in Global by End User (2021-2030)
  • Figure 7 Blood Glucose Monitoring Systems Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Blood Glucose Monitoring Systems Market Analysis in North America (2021-2030)
  • Figure 9 Blood Glucose Monitoring Systems Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Blood Glucose Monitoring Systems Market Analysis in North America by Modality (2021-2030)
  • Figure 11 Blood Glucose Monitoring Systems Market Analysis in North America by End User (2021-2030)
  • Figure 12 Blood Glucose Monitoring Systems Market Analysis in North America by Country (2021-2030)
  • Figure 13 Blood Glucose Monitoring Systems Market Analysis in the US (2021-2030)
  • Figure 14 Blood Glucose Monitoring Systems Market Analysis in Canada (2021-2030)
  • Figure 15 Blood Glucose Monitoring Systems Market Analysis in Mexico (2021-2030)
  • Figure 16 Blood Glucose Monitoring Systems Market Analysis in Europe (2021-2030)
  • Figure 17 Blood Glucose Monitoring Systems Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Blood Glucose Monitoring Systems Market Analysis in Europe by Modality (2021-2030)
  • Figure 19 Blood Glucose Monitoring Systems Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Blood Glucose Monitoring Systems Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Blood Glucose Monitoring Systems Market Analysis in France (2021-2030)
  • Figure 22 Blood Glucose Monitoring Systems Market Analysis in Germany (2021-2030)
  • Figure 23 Blood Glucose Monitoring Systems Market Analysis in the UK (2021-2030)
  • Figure 24 Blood Glucose Monitoring Systems Market Analysis in Italy (2021-2030)
  • Figure 25 Blood Glucose Monitoring Systems Market Analysis in Spain (2021-2030)
  • Figure 26 Blood Glucose Monitoring Systems Market Analysis in Russia (2021-2030)
  • Figure 27 Blood Glucose Monitoring Systems Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Modality (2021-2030)
  • Figure 31 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Blood Glucose Monitoring Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Blood Glucose Monitoring Systems Market Analysis in China (2021-2030)
  • Figure 34 Blood Glucose Monitoring Systems Market Analysis in Japan (2021-2030)
  • Figure 35 Blood Glucose Monitoring Systems Market Analysis in India (2021-2030)
  • Figure 36 Blood Glucose Monitoring Systems Market Analysis in Australia (2021-2030)
  • Figure 37 Blood Glucose Monitoring Systems Market Analysis in South Korea (2021-2030)
  • Figure 38 Blood Glucose Monitoring Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Blood Glucose Monitoring Systems Market Analysis in Rest of World (2021-2030)
  • Figure 40 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Modality (2021-2030)
  • Figure 42 Blood Glucose Monitoring Systems Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Blood Glucose Monitoring Systems Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Blood Glucose Monitoring Systems Market Analysis in the Middle East (2021-2030)
  • Figure 45 Blood Glucose Monitoring Systems Market Analysis in Africa (2021-2030)
  • Figure 46 Blood Glucose Monitoring Systems Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0013

Blood Glucose Monitoring Systems Market By Product Type (Self-Monitoring Blood Glucose Systems And Continuous Glucose Monitoring Systems), By Modality (Wearable And Non-Wearable), By End-User (Hospitals, Home Care Settings, And Others), by geography, is expected to expand at a noteworthy CAGR till 2030 owing to the growing prevalence of diabetes across the globe and technological advancements in the blood glucose monitoring systems.

The global blood glucose monitoring systems market was valued at USD 13.06 billion in 2023, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030, in order to reach USD 20.40 billion by 2030. The escalating demand for blood glucose monitoring systems is predominantly attributed to the increasing prevalence of diabetes among the population across the globe, the growing burden of the geriatric population who are susceptible to developing hyperglycemia. In addition, the spike in technologically advanced blood glucose monitoring devices product launch and government initiatives to raise awareness regarding proper diabetes management, among others are the factors likely to spur the global blood glucose monitoring systems market.

Blood Glucose Monitoring Systems Market Dynamics:

The market for blood glucose monitoring systems is gaining momentum at present owing to the increasing prevalence of diabetes among the worldwide population. According to the International Diabetes Federation Atlas Ninth edition 2019, approximately 463 million adults aged between 20-79 years of age were living with diabetes across the globe in the year 2019 which is expected to rise to 700 million by the year 2045.

The above-mentioned source also stated that about 1.1 million children and adolescents are living with type I diabetes and around 20 million live births (1 in 6 live births) are affected by diabetes during pregnancy. Thus, for adequate management of diabetes, proper blood glucose monitoring is necessary which increases the demand for blood glucose monitoring systems during the forecasted period.

Also, the growing geriatric population who are susceptible to developing diabetes is expected to raise the demand for blood glucose monitoring systems. According to the United Nations World Population Ageing 2019 highlights, there were about 703 million persons aged 65 years or over in the world in the year 2019, and the number of older persons is projected to double to 1.5 billion by the year 2050. Moreover, as per the American Diabetes Association 2022 data, the percentage of Americans age 65 and older with diabetes remained high, at 26.8%, or 14.3 million seniors in the US in the year 2018.

In addition, approval of technologically advanced blood glucose monitoring systems is also anticipated to surge the market for blood glucose monitoring systems. For instance, on September 28, 2020, Abbott secured the CE mark for its next-generation FreeStyle Libre 3 system, comprising the world's smallest, thinnest sensor and delivers continuous and real-time glucose readings automatically to smartphones.

Hence, all the aforementioned factors are expected to contribute to the blood glucose monitoring systems market during the forecasted period.

However, the high cost associated with the blood glucose monitoring systems is likely to impede the market.

The unprecedented COVID-19 pandemic has a limited effect on the blood glucose monitoring system. This is because the issuance of FDA guidelines for using home-use blood glucose meters in hospitals during the COVID-19 pandemic can facilitate remote patient monitoring. Moreover, extended use of continuous glucose monitoring systems to hospitalized patients during the COVID-19 emergency to allow hospital staff to remotely monitor glucose in patients also boost the demand for the glucose monitoring systems despite nationwide lockdowns, sluggish demand, and supply chain due to logistical restrictions.

Blood Glucose Monitoring Systems Market Segment Analysis:

Blood Glucose Monitoring Systems Market By Product Type (Self-Monitoring Blood Glucose Systems and Continuous Glucose Monitoring Systems), By Modality (Wearable and Non-Wearable), By End-User (Hospitals, Home Care Settings, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Blood Glucose Monitoring Systems product segment, continuous glucose monitoring systems (CGM) are anticipated to hold a significant market share during the forecasted period. This is because the advantage of providing real-time and dynamic information about the trends of the glucose levels unlike a single reading exhibited by the CGM systems for improved glycemic control is likely to raise the demand for these systems.

Additionally, the rise in key market players' initiative toward the development of advanced CGM systems for diabetic patients for proper diabetes care and management is further expected to grow the market for CGM systems. For instance, on February 11, 2020, Senseonics Holdings, Inc., a medical technology company focused on the development of implantable continuous glucose monitoring (CGM) system entered into an agreement with Companion Medical to integrate Eversense® CGM System real-time glucose data with the Companion Medical InPen(TM) smart system for insulin delivery.

Also, on April 05, 2019, WaveForm Technologies, Inc. a wholly-owned subsidiary of WaveForm Diabetes (formerly AgaMatrix Holdings, LLC) and developer of novel products for continuous glucose monitoring entered into a partnership with A. Menarini Diagnostics S.r.l. to commercialize the WaveForm Technologies Continuous Glucose Monitor (CGM).

Furthermore, the product launch of the continuous glucose monitoring system for people with gestational diabetes is also projected to spike the segmental growth of the blood glucose monitoring systems. For instance, in November 2020, Abbott, launched the FreeStyle® Libre system for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy).

Thus, all the above-mentioned factors are likely to upsurge the market for blood glucose monitoring systems.

North America is expected to dominate the Overall Blood Glucose Monitoring Systems Market:

Among all the regions, North America is expected to hold a major share in the overall blood glucose monitoring systems market during the forecasted period. This domination is owing to the rising burden of the diabetic population in the region. Moreover, the increasing prevalence of obesity in the region which accounts for between 80 and 85% of the risk of developing type 2 diabetes is also anticipated to raise the demand for blood glucose monitoring systems in the coming years. In addition, the rising adoption of technologically advanced glucose monitoring systems, and rigorous glucose monitoring product approvals and launches in the region for better diabetes management also contribute to the regional blood glucose monitoring systems market.

For instance, according to the Centres for Disease Control and Prevention (CDC) 2020 data, about 34.2 million Americans have diabetes. The data also mentioned that out of the total diabetic population in the region 15% were smokers, 89% were overweight, and 38% were physically inactive.

In addition, according to the data published by Diabetes Canada, a national health charity, in the year 2020, approximately 11 million Canadians are living with diabetes or prediabetes. Thus, the surge in the diabetic population in the region will boost the demand for blood glucose monitoring systems.

Furthermore, a rise in blood glucose monitoring product launches in the region will also lead to the growth of the glucose monitoring systems market in the region. For instance, in November 2022, Intuity Medical launched the POGO Automatic Blood Glucose Monitoring System for diabetes patients in the US.

Hence, all the above-stated factors are expected to propel the blood glucose monitoring systems market in the region.

Also, the APAC region has future potential for the blood glucose monitoring systems market. This is owing to the rising burden of the targeted population in the region, the growing geriatric population. Moreover, the continuous efforts by the leading companies to introduce continuous glucose monitoring systems in the region will also fuel the blood glucose monitoring systems market. For instance, on July 27, 2022, Terumo launched the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Japan, which is manufactured by Dexcom, Inc. Also, in the year 2019, Medtronic partnered with Handok to market and distribute Medtronic's Guardian Connect and iPro 2 continuous glucose monitoring system in South Korea.

In addition, improved healthcare infrastructure, and increasing disposable income in the region will also boost the blood glucose monitoring systems market in the region.

Blood Glucose Monitoring Systems Market Players:

Some of the key market players operating in the Blood Glucose Monitoring Systems market include Medtronic, Abbott, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings (Johnson & Johnson), Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., A. Menarini Diagnostics s.r.l, Bionime Corporation., MEDISANA GMBH, Nemaura., and others.

Recent Developmental Activities in the Blood Glucose Monitoring Systems Market:

On August 24, 2022, Smart Meter, the leader in cellular-connected remote patient monitoring (RPM) devices, data, and services, announced the availability of its iGlucose monitor for managing gestational diabetes.

On February 19, 2020, DexCom, Inc. and Insulet Corporation entered into a commercialization agreement to combine current and future Dexcom continuous glucose monitoring systems (CGM) with Insulet's trusted tubeless insulin delivery Pod into the Omnipod Horizon(TM) System for automated insulin delivery, currently in the pivotal trial.

On February 19, 2020, Abbott and Insulet Corporation partnered to integrate Abbott's world-leading continuous glucose sensing technology with Insulet's next-generation tubeless system, the Omnipod Horizon(TM) Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes.

Key Takeaways from the Blood Glucose Monitoring Systems Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Blood Glucose Monitoring Systems market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Blood Glucose Monitoring Systems Market.

Various opportunities available for the other competitor in the Blood Glucose Monitoring Systems Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Blood Glucose Monitoring Systems market growth in the coming future?

Target Audience who can be benefited from the Blood Glucose Monitoring Systems Market Report Study

Blood Glucose Monitoring Systems providers

Research organizations and consulting companies

Blood Glucose Monitoring Systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Blood Glucose Monitoring Systems

Various End-users who want to know more about the Blood Glucose Monitoring Systems Market and the latest technological developments in the Blood Glucose Monitoring Systems market.

Frequently Asked Questions for the Blood Glucose Monitoring Systems Market:

1. What are Blood Glucose Monitoring Systems?

Blood glucose monitoring systems are used at home or in health care settings to measure/monitor the amount glucose level in the blood. There are two types of blood glucose monitors available in the market - self-monitoring blood glucose monitoring systems and continuous glucose monitoring systems.

2. What is the market for Global Blood Glucose Monitoring Systems?

The global blood glucose monitoring systems market was valued at USD 13.06 billion in 2023, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030, in order to reach USD 20.40 billion by 2030.

3. What are the drivers for the Global Blood Glucose Monitoring Systems?

The major factors driving the demand for Blood Glucose Monitoring Systems are the growing prevalence of diabetes among the worldwide population. Moreover, technological advancement in the product portfolio, growing geriatric population, and rising government initiatives to raise awareness regarding proper diabetes management are also expected to boost the market.

4. What are the key players operating in Global Blood Glucose Monitoring Systems?

Some of the key market players operating in the Blood Glucose Monitoring Systems market include Medtronic, Abbott, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings (Johnson & Johnson), Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., A. Menarini Diagnostics s.r.l, Bionime Corporation., MEDISANA GMBH, Nemaura., and others.

5. Which region has the highest share in the Blood Glucose Monitoring Systems market?

Among all the regions, North America is expected to hold a major share in the overall blood glucose monitoring systems market during the forecasted period, 2024-2030. This domination is owing to the rising burden of the diabetic population in the region. Moreover, the increasing prevalence of obesity in the region which is the major risk factor for developing type 2 diabetes is also anticipated to raise the demand for blood glucose monitoring systems in the coming years. In addition, the rising adoption of technologically advanced glucose monitoring systems, and rigorous glucose monitoring product approvals and launches in the region for better diabetes management also contribute to the regional blood glucose monitoring systems market.

Table of Contents

1.Blood Glucose Monitoring Systems Market Report Introduction

2.Blood Glucose Monitoring Systems Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Blood Glucose Monitoring Systems Market Key factors analysis

  • 4.1 Blood Glucose Monitoring Systems Market Drivers
    • 4.1.1 Growing prevalence of diabetes
    • 4.1.2 The increasing burden of the old age population
    • 4.1.3 Rise in approval of various Blood Glucose Monitoring Systems
    • 4.1.4 Rapid technological advancement in the products
  • 4.2 Blood Glucose Monitoring Systems Market Restraints and Challenges
    • 4.2.1 High cost of the Blood Glucose Monitoring Systems
    • 4.2.2 Lower diagnosis and treatment rates in emerging nations may restrict blood glucose monitoring systems adoption
  • 4.3 Blood Glucose Monitoring Systems Market Opportunities
    • 4.3.1 Strategic business activities by key players for market expansion also provide growth opportunities
    • 4.3.2 Rise in government initiatives to raise awareness in low and middle-income nations may provide an opportunity to the market

5. Blood Glucose Monitoring Systems Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Blood Glucose Monitoring Systems Market

7. Blood Glucose Monitoring Systems Market layout

  • 7.1 By Product Type
    • 7.1.1 Self-Monitoring Blood Glucose Systems
    • 7.1.2 Continuous Glucose Monitoring Systems
  • 7.2 By Modality
    • 7.2.1 Wearable
    • 7.2.2 Non-wearable
  • 7.3 By End-user
    • 7.3.1 Hospitals
    • 7.3.2 Home care settings
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.1.2 North America Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.1.3 North America Blood Glucose Monitoring Systems Market, by End User
      • 7.4.1.4 North America Blood Glucose Monitoring Systems Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.2.2 Europe Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.2.3 Europe Blood Glucose Monitoring Systems Market, by End User
      • 7.4.2.4 Europe Blood Glucose Monitoring Systems Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.3.2 Asia-Pacific Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.3.3 Asia-Pacific Blood Glucose Monitoring Systems Market, by End User
      • 7.4.3.4 Asia-Pacific Blood Glucose Monitoring Systems Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Blood Glucose Monitoring Systems Market, by Product Type
      • 7.4.4.2 RoW Blood Glucose Monitoring Systems Market, by Modality
      • 7.4.4.3 RoW Blood Glucose Monitoring Systems Market, by End User
      • 7.4.4.4 RoW Blood Glucose Monitoring Systems Market, by Region
      • 7.4.4.1 Middle East
      • 7.4.4.2 Africa
      • 7.4.4.3 South America

8. Blood Glucose Monitoring Systems Global Company Share Analysis - Key 3-5 Companies

9. Blood Glucose Monitoring Systems Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Abbott
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 F. Hoffmann-La Roche Ltd
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 LifeScan IP Holdings (Johnson & Johnson)
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Dexcom Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 ARKRAY, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Senseonics
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 WaveForm Technologies, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 B. Braun Melsungen AG
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Ascensia Diabetes Care Holdings AG.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Ypsomed
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 i-SENS, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Intuity Medical, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 ACON Laboratories, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Prodigy Diabetes Care, LLC
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Sinocare
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Rossmax International Ltd.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Menarini Diagnostics s.r.l
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Bionime Corporation.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Nemaura.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us